Completed OBSERVATIONAL NCT00902434

Non-Hodgkin Lymphoma in Elderly Patients Above the Age of 80 in the Rituximab Era

Retrospective Analysis of Histologies, Pattern of Care, and Outcomes of Non-Hodgkin Lymphoma in Elderly Patients Above the Age of 80 in the Rituximab Era: A Report From the Chicago Lymphoma Consortium

Sponsor: Oncology Specialists, S.C.

Conditions Non-Hodgkin's Lymphoma

Updated 7 times since 2017 Last updated: Jun 30, 2014 Started: May 31, 2009 Primary completion: Feb 28, 2011 Completion: Apr 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Non-Hodgkin's Lymphoma, this trial is completed. The trial is conducted by Oncology Specialists, S.C. and has accumulated 7 data snapshots since 2009. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Jan 2026 — Present [monthly]

Completed
Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

May 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Oncology Specialists, S.C.

Data source: Oncology Specialists, S.C.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.